Pharma and Biotech (DLS30)

 0.00
   
  • 52 Week High: NULL
  • 52 Week Low: 0.00

Latest ShareCast News

Berenberg downgrades GSK to 'hold' ahead of product rollouts

By Iain Gilbert

Date: Tuesday 03 Jun 2025

(Sharecast News) - Analysts at Berenberg downgraded drugmaker GSK from 'buy' to 'hold' on Tuesday as it awaited upcoming product launches.

Hutchmed China upbeat on results from lung cancer trial

By Josh White

Date: Monday 02 Jun 2025

(Sharecast News) - Hutchmed China reported positive interim results from its phase three 'SACHI' trial on Monday, showing that the combination of savolitinib and osimertinib significantly improved progression-free survival (PFS) in patients with advanced EGFR mutation-positive non-small cell lung cancer (NSCLC) and MET amplification, following progression on first-line EGFR inhibitor therapy.

Indivior to cancel secondary listing in London

By Benjamin Chiou

Date: Monday 02 Jun 2025

(Sharecast News) - Drugmaker Indivior has announced plans to cancel its secondary listing in London, just a year after moving its primary listing to the Nasdaq.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 0.00
Closing Price Change 0.00
% Change 0.00 %
--25 Close 0.00

Top Risers

Price Change
VRCI 1.63p +18.2%
HCM 217.00p +8.0%
POLB 3.40p +6.3%
FUM 9.70p +4.9%
OPTI 13.35p +4.3%
HELD 0.99p +4.2%
INDV 953.50p +4.1%
ANIC 6.78p +4.0%
IXI 11.25p +2.3%
HEMO 178.50p +2.1%

Top Fallers

Price Change
VAL 0.48p -13.6%
FARN 230.00p -8.9%
NFX 0.10p -6.8%
AVCT 35.00p -5.4%
TCF 0.27p -3.6%
CIZ 1.80p -2.7%
HLN 405.10p -2.2%
ONT 118.90p -2.1%
GSK 1,485.00p -2.1%
SVNS 0.13p -1.9%

Top of Page